Data from the BREADTH Phase 2b asthma trial is expected to be reported in late-2027Data from the ongoing parallel BROADEN2 Phase 2b atopic ...
New eTMF module integrates with Enlighten Clinical Solutions’ platform to support inspection-ready clinical trial ...
Data from the BREADTH Phase 2b asthma trial is expected to be reported in late-2027 Data from the ongoing parallel BROADEN2 Phase 2b atopic dermatitis trial is expected to be reported by mid-2027 WATE ...
Nine-month findings show mean improvement in Composite Unified Huntington's Disease Rating Scale from baseline of +0.64 ...
Use ESG signals to inform the overall risk posture of a supplier and the intensity of oversight. This does not require turning GCP audits into ESG audits. It means including ESG in risk-based thinking ...
ABP News on MSN
Minex Melt Treatment Pvt Ltd Appoints Sharath Kumar As Chief Executive Officer, Reinforcing Its Belief In Long-Term People Development
Mumbai: Minex Melt Treatment Pvt Ltd today announced the appointment of Sharath Kumar, a mechanical engineer by qualification ...
Phase 2 Data Strengthened, Strong Cash Position, and Phase 3 Planning Well Advanced −Highlights Phase 2 data for ATH434 in Multiple System ...
The real “commercial launch” happens years before launch preparation officially begins. Once Phase III begins, your evidence ...
In an era where AI-driven drug discovery accelerates candidate generation faster than traditional systems can evaluate them, ...
Relay Therapeutics upgraded to Outperform: zovegalisib PI3Kα breast cancer catalyst, $596M cash to 2029, Phase 3 mid-2026.
Today, a closely watched 'bellwether trial' has kicked off in Los Angeles against some of the world's largest social media ...
The yellow cards experiment enters year two, but questions remain about fairness, deterrence, and whether it's making pro ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results